Available Technologies

TAK1 Inhibitors as Anti-Cancer Agents

HLA Class II Peptide Mimics

Anti-Idiotypic Peptide Sequences

GD3 Peptide Mimics

GD2 Peptide Mimics

Oncogenic Kinase-Activated Anti-Cancer Therapy

Anti-Tumor Augmentation for Epithelial Ovarian Cancer

Modulation of Hematopoiesis and Inflammatory Cell Production by ST6Gal-1